Related Experiment Video

Updated: Feb 19, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

19.1K

Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection

Colleen S Curran1, Thomas Bolig1, Parizad Torabi-Parizi1

  • 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.

American Journal of Respiratory and Critical Care Medicine
|November 1, 2017
PubMed

Insights

Pseudomonas aeruginosa, a priority pathogen, damages lung defenses and evades immune responses. Understanding these interactions is key to developing new therapies against this antibiotic-resistant bacterium.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Pseudomonas aeruginosa is a gram-negative bacterium causing nosocomial infections and antibiotic resistance.
  • It disrupts lung homeostasis by damaging epithelium and evading immune responses.
  • Understanding P. aeruginosa pathogenesis is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the mechanisms by which P. aeruginosa interacts with and overcomes host defense systems in the lung.
  • To explore how P. aeruginosa disrupts airway homeostasis and immune evasion.

Main Methods:

  • Review of P. aeruginosa virulence factors including flagella, pili, and type III secretion system.
  • Analysis of quorum-sensing molecules and their role in infection spread.
  • Discussion of pathogen interactions with lung epithelial cells and immune cells.

Main Results:

  • P. aeruginosa employs multiple strategies to damage host defenses.
  • Virulence factors directly interact with host cells, disrupting epithelial integrity.
  • Quorum sensing regulates factors promoting infection dissemination.

Conclusions:

  • P. aeruginosa pathogenesis involves complex interactions with host cells and immune evasion.
  • Targeting these pathogen-host interactions offers potential therapeutic strategies.
  • Further research into these pathways can guide the development of novel treatments.
Keywords:
Pseudomonas aeruginosaimmunologyquorum sensingtherapeuticstype III secretion system

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.8K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.9K

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
742
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
845
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
964
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.3K